The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review-Reference-Cited by-同舟云学术

The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review

Published:2016-08-05 Issue:11 Volume:16 Page:1387-1401
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Di Lorenzo Giuseppe,De Placido Sabino,Pagliuca Martina,Ferro Matteo,Lucarelli Giuseppe,Rossetti Sabrina,Bosso Davide,Puglia Livio,Pignataro Piero,Ascione Ilaria,De Cobelli Ottavio,Caraglia Michele,Aieta Michele,Terracciano Daniela,Facchini Gaetano,Buonerba Carlo,Sonpavde Guru

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1080/14712598.2016.1216964

Reference106 articles.

1. PROGNOSTIC ROLE OF FUHRMAN GRADE AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN pT1a CLEAR CELL CARCINOMA IN PARTIAL NEPHRECTOMY SPECIMENS

2. Long-Term Survival Rates after Resection for Locally Advanced Kidney Cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 Experience

3. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silencing MUC1 to regulate intracellular lipid metabolism: Overcoming sunitinib resistance and inhibiting metastasis in renal cell carcinoma;Chemical Engineering Journal;2024-09

2. A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC;Molecular Pharmaceutics;2024-06-04

3. MIER2/PGC1A elicits sunitinib resistance via lipid metabolism in renal cell carcinoma;Journal of Advanced Research;2024-05

4. Multi-omics and immunogenomics analysis revealed PFKFB3 as a targetable hallmark and mediates sunitinib resistance in papillary renal cell carcinoma: in silico study with laboratory verification;European Journal of Medical Research;2024-04-15

5. The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features;Frontiers in Pharmacology;2023-12-20